{"id":"triomune","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":["Stavudine","Lamivudine","Nevirapine"],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Triomune","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:30:10.491043+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:30:17.019424+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Triomune","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:30:17.392327+00:00"}},"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"_scrapedAt":"2026-03-28T00:14:33.195Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:30:19.426025+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT00495326","phase":"PHASE2, PHASE3","title":"Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)","status":"COMPLETED","sponsor":"French National Agency for Research on AIDS and Viral Hepatitis","startDate":"2007-12","conditions":"Tuberculosis, Aids, Hiv Infections","enrollment":570},{"nctId":"NCT00617643","phase":"PHASE4","title":"Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis","status":"COMPLETED","sponsor":"Makerere University","startDate":"2008-05","conditions":"HIV Infections, Tuberculosis","enrollment":18},{"nctId":"NCT00620438","phase":"PHASE4","title":"Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients","status":"UNKNOWN","sponsor":"Makerere University","startDate":"2008-02","conditions":"HIV Infections, Tuberculosis","enrollment":90},{"nctId":"NCT01174914","phase":"PHASE2","title":"Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+","status":"COMPLETED","sponsor":"The Ojai Foundation","startDate":"2008-03","conditions":"HIV Seropositivity","enrollment":171},{"nctId":"NCT00380770","phase":"PHASE4","title":"HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT","status":"COMPLETED","sponsor":"University of KwaZulu","startDate":"2003-01","conditions":"HIV, AIDS, Kaposi's Sarcoma","enrollment":112},{"nctId":"NCT01025830","phase":"PHASE4","title":"Triomune Bioequivalence With Innovators","status":"COMPLETED","sponsor":"Makerere University","startDate":"2006-02","conditions":"HIV/AIDS","enrollment":20},{"nctId":"NCT00455585","phase":"PHASE4","title":"Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products","status":"COMPLETED","sponsor":"Makerere University","startDate":"2007-01","conditions":"HIV Infections","enrollment":18}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":34,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Triomune","genericName":"Triomune","companyName":"Makerere University","companyId":"makerere-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:30:19.426025+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}